Hodgkin Lymphoma

Hodgkin lymphoma, a type of cancer that starts in the lymphatic system, is one of the most curable forms of cancer. Our hematologist–oncologists, radiation oncologists, and radiologists offer personalized treatment plans to help people achieve remission, in which no cancer cells can be detected. Treatment approaches may include chemotherapy, radiation therapy, and rarely, stem cell transplantation. Our compassionate doctors and support staff ensure you have the psychological support you need throughout treatment and beyond.

Clinical Trials and Research Studies

Phase 1

An Open Label First in Human (FIH) Phase 1 Trial of LVGN6051 as Single Agent and in Combination with Keytruda (pembrolizumab) in Advanced or Metastatic Malignancy

Learn More

Phase 2

A Phase 2 Trial of the Combination of Polatuzumab Vedotin Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma

Learn More

Phase 1

A PHASE Ib STUDY EVALUATING THE SAFETY EFFICACY AND PHARMACOKINETICS OF VENETOCLAX IN COMBINATION WITH POLATUZUMAB VEDOTIN PLUS RITUXIMAB (R) AND CYCLOPHOSPHAMIDE DOXORUBICIN PREDNISONE (CHP) IN PATIENTS WITH UNTREATED BCL-2 IMMUNOHISTOCHEMISTRY (IHC) POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA

Learn More

Phase 1

A PHASE 1 OPEN-LABEL DOSE FINDING STUDY OF CC-95251 A MONOCLONAL ANTIBODY DIRECTED AGAINST SIRPa ALONE AND IN COMBINATION WITH CETUXIMAB OR RITUXIMAB IN SUBJECTS WITH ADVANCED SOLID AND HEMATOLOGIC CANCERS

Learn More